{"version":"1.0","provider_url":"https:\/\/warpwire.duke.edu","provider_name":"Warpwire","is_public":true,"duration":3589,"has_caption":true,"links":{"caption":[{"label":"English","url":"https:\/\/warpwire.duke.edu\/api\/caption\/CQ4GAA\/51003\/vtt\/?nonce=059277d65d89d873841d659926595710&expiration=1780624800&signature=86d2ed4cb874bbe4cc95f0fd9c16adbb41cfe380c3c873cb0696d8169249df9e"}]},"views":8,"upload_date":"2021-09-10T17:58:48+00:00","description":"\"Overcoming Resistance to PD-1 Immunotherapy in Advanced Melanoma\"\r\n\r\nApril Salama, MD\r\nAssociate Professor of Medicine (Medical Oncology)\r\nDirector, Melanoma Disease Group\r\nDuke Cancer Institute \r\n\r\nBrent Hanks, MD, PhD\r\nAssociate Professor of Medicine (Medical Oncology)\r\nAssistant Professor, Department of Pharmacology and Cancer Biology\r\nAssociate Director of Basic and Translational Research, Duke Center for Cancer Immunotherapy\r\nAssociate Director of Translational Sciences, Melanoma Program\r\nDuke University, Duke Cancer Institute","author_name":"Brittany Vekstein","html":"\u003Ciframe width=\"640\" height=\"360\" src=\"https:\/\/warpwire.duke.edu\/w\/CQ4GAA\/\" frameborder=\"0\" allow=\"autoplay; encrypted-media; camera; microphone; picture-in-picture\" allowfullscreen\u003E\u003C\/iframe\u003E","height":360,"width":640,"thumbnail_height":360,"thumbnail_width":640,"url":"https:\/\/warpwire.duke.edu\/w\/CQ4GAA\/","type":"video","title":"Medicine Grand Rounds - September 10, 2021","thumbnail_url":"https:\/\/warpwire.duke.edu\/img\/8B95662D-4844-44D1-AC89-AD51D8D1F453\/0A46736C-8672-4362-A985-D449C37729C8\/large\/"}